SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Jensen Elisabeth Kjaer)
 

Sökning: WFRF:(Jensen Elisabeth Kjaer) > Population pharmaco...

Population pharmacokinetic–pharmacodynamic model of subcutaneous bupivacaine in a novel extended-release microparticle formulation

Storgaard, Ida Klitzing (författare)
University of Copenhagen
Jensen, Elisabeth Kjær (författare)
Copenhagen University Hospital
Bøgevig, Søren (författare)
Copenhagen University Hospital
visa fler...
Balchen, Torben (författare)
Copenhagen University Hospital
Springborg, Anders Holten (författare)
Copenhagen University Hospital
Royal, Mike Allan (författare)
Møller, Kirsten (författare)
Copenhagen University Hospital,University of Copenhagen
Werner, Mads Utke (författare)
Lund University,Lunds universitet,Tumörmikromiljö,Sektion I,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Tumor microenvironment,Section I,Department of Clinical Sciences, Lund,Faculty of Medicine,Copenhagen University Hospital
Lund, Trine Meldgaard (författare)
University of Copenhagen
visa färre...
 (creator_code:org_t)
Engelska.
Ingår i: Basic and Clinical Pharmacology and Toxicology. - 1742-7835.
  • Tidskriftsartikel (refereegranskat)
Abstract Ämnesord
Stäng  
  • The objective of this study was to develop a population pharmacokinetic–pharmacodynamic model of subcutaneously administered bupivacaine in a novel extended-release microparticle formulation for postoperative pain management. Bupivacaine was administered subcutaneously in the lower leg to 28 healthy male subjects in doses from 150 to 600 mg in a phase 1 randomized, placebo-controlled, double-blind, dose-ascending study with two different microparticle formulations, LIQ865A and LIQ865B. Warmth detection threshold was used as a surrogate pharmacodynamic endpoint. Population pharmacokinetic–pharmacodynamic models were fitted to plasma concentration-effect-time data using non-linear mixed-effects modelling. The pharmacokinetics were best described by a two-compartment model with biphasic absorption as two parallel absorption processes: a fast, zero-order process and a slower, first-order process with two transit compartments. The slow absorption process was found to be dose-dependent and rate-limiting for elimination at higher doses. Apparent bupivacaine clearance and the transit rate constant describing the slow absorption process both appeared to decrease with increasing doses following a power function with a shared covariate effect. The pharmacokinetic–pharmacodynamic relationship between plasma concentrations and effect was best described by a linear function. This model gives new insight into the pharmacokinetics and pharmacodynamics of microparticle formulations of bupivacaine and the biphasic absorption seen for several local anaesthetics.

Ämnesord

MEDICIN OCH HÄLSOVETENSKAP  -- Medicinska och farmaceutiska grundvetenskaper -- Farmaceutiska vetenskaper (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Basic Medicine -- Pharmaceutical Sciences (hsv//eng)

Nyckelord

bupivacaine
local anaesthesia
pain management
pharmacokinetics
PKPD modelling

Publikations- och innehållstyp

art (ämneskategori)
ref (ämneskategori)

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy